Literature DB >> 32440702

Evidence of distinct α-synuclein strains underlying disease heterogeneity.

Sara A M Holec1, Amanda L Woerman2.   

Abstract

Synucleinopathies are a group of neurodegenerative disorders caused by the misfolding and self-templating of the protein α-synuclein, or the formation of α-synuclein prions. Each disorder differs by age of onset, presenting clinical symptoms, α-synuclein inclusion morphology, and neuropathological distribution. Explaining this disease-specific variability, the strain hypothesis postulates that each prion disease is encoded by a distinct conformation of the misfolded protein, and therefore, each synucleinopathy is caused by a unique α-synuclein structure. This review discusses the current data supporting the role of α-synuclein strains in disease heterogeneity. Several in vitro and in vivo models exist for evaluating strain behavior, however, as the focus of this article is to compare strains across synucleinopathy patients, our discussion predominantly focuses on the two models most commonly used for this purpose: the α-syn140*A53T-YFP cell line and the TgM83+/- mouse model. Here we define each strain based on biochemical stability, ability to propagate in α-syn140-YFP cell lines, and incubation period, inclusion morphology and distribution, and neurological signs in TgM83+/- mice.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32440702     DOI: 10.1007/s00401-020-02163-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  99 in total

1.  The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure.

Authors:  David R Boyer; Binsen Li; Chuanqi Sun; Weijia Fan; Kang Zhou; Michael P Hughes; Michael R Sawaya; Lin Jiang; David S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-03       Impact factor: 11.205

2.  Robust Central Nervous System Pathology in Transgenic Mice following Peripheral Injection of α-Synuclein Fibrils.

Authors:  Jacob I Ayers; Mieu M Brooks; Nicola J Rutherford; Jasie K Howard; Zachary A Sorrentino; Cara J Riffe; Benoit I Giasson
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

3.  A Proposed Atomic Structure of the Self-Assembly of the Non-Amyloid-β Component of Human α-Synuclein As Derived by Computational Tools.

Authors:  Yoav Atsmon-Raz; Yifat Miller
Journal:  J Phys Chem B       Date:  2015-07-22       Impact factor: 2.991

4.  Localized Induction of Wild-Type and Mutant Alpha-Synuclein Aggregation Reveals Propagation along Neuroanatomical Tracts.

Authors:  Jacob I Ayers; Cara J Riffe; Zachary A Sorrentino; Jeffrey Diamond; Eric Fagerli; Mieu Brooks; Ahmad Galaleldeen; P John Hart; Benoit I Giasson
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

5.  [Alpha-methyl -para-tyrosine in the prolonged treatment of malignant pheochromocytoma and preoperative care of benign pheochromocytoma: preliminary study].

Authors:  P Tcherdakoff; J Menard; J Bedrossian; J Vaysse; J M Alexandre; J M Desmonts; P Milliez
Journal:  J Urol Nephrol (Paris)       Date:  1972-09

Review 6.  The neuropathology, pathophysiology and genetics of multiple system atrophy.

Authors:  Z Ahmed; Y T Asi; A Sailer; A J Lees; H Houlden; T Revesz; J L Holton
Journal:  Neuropathol Appl Neurobiol       Date:  2012-02       Impact factor: 8.090

7.  The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease.

Authors:  Jacob I Ayers; Charles R Schutt; Ronald A Shikiya; Adriano Aguzzi; Anthony E Kincaid; Jason C Bartz
Journal:  PLoS Pathog       Date:  2011-03-17       Impact factor: 6.823

8.  Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS.

Authors:  Emmanuel A Asante; Andrew Grimshaw; Michelle Smidak; Tatiana Jakubcova; Andrew Tomlinson; Asif Jeelani; Shyma Hamdan; Caroline Powell; Susan Joiner; Jacqueline M Linehan; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  PLoS Pathog       Date:  2015-07-02       Impact factor: 6.823

9.  Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs.

Authors:  David R Boyer; Binsen Li; Chuanqi Sun; Weijia Fan; Michael R Sawaya; Lin Jiang; David S Eisenberg
Journal:  Nat Struct Mol Biol       Date:  2019-11-06       Impact factor: 15.369

10.  Structural and functional characterization of two alpha-synuclein strains.

Authors:  Luc Bousset; Laura Pieri; Gemma Ruiz-Arlandis; Julia Gath; Poul Henning Jensen; Birgit Habenstein; Karine Madiona; Vincent Olieric; Anja Böckmann; Beat H Meier; Ronald Melki
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  26 in total

Review 1.  Consequences of variability in α-synuclein fibril structure on strain biology.

Authors:  Sara A M Holec; Samantha L Liu; Amanda L Woerman
Journal:  Acta Neuropathol       Date:  2022-02-04       Impact factor: 17.088

2.  α-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders.

Authors:  Ivan Martinez-Valbuena; Emily Swinkin; Enrique Santamaria; Joaquin Fernandez-Irigoyen; Valerie Sackmann; Ain Kim; Jun Li; Paulina Gonzalez-Latapi; Greg Kuhlman; Suvorit Subhas Bhowmick; Naomi P Visanji; Anthony E Lang; Gabor G Kovacs
Journal:  Acta Neuropathol       Date:  2022-06-24       Impact factor: 15.887

3.  Clinicopathological correlates of pyramidal signs in multiple system atrophy.

Authors:  Chi-Ying R Lin; Anisha Viswanathan; Tiffany X Chen; Hiroshi Mitsumoto; Jean P Vonsattel; Phyllis L Faust; Sheng-Han Kuo
Journal:  Ann Clin Transl Neurol       Date:  2022-05-20       Impact factor: 5.430

4.  Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice.

Authors:  Grace M Lloyd; Zachary A Sorrentino; Stephan Quintin; Kimberly-Marie M Gorion; Brach M Bell; Giavanna Paterno; Brooke Long; Stefan Prokop; Benoit I Giasson
Journal:  Acta Neuropathol       Date:  2022-04-30       Impact factor: 15.887

Review 5.  The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease.

Authors:  Heather H C Lau; Martin Ingelsson; Joel C Watts
Journal:  Acta Neuropathol       Date:  2020-08-02       Impact factor: 17.088

6.  The structural heterogeneity of α-synuclein is governed by several distinct subpopulations with interconversion times slower than milliseconds.

Authors:  Jiaxing Chen; Sofia Zaer; Paz Drori; Joanna Zamel; Khalil Joron; Nir Kalisman; Eitan Lerner; Nikolay V Dokholyan
Journal:  Structure       Date:  2021-05-19       Impact factor: 5.871

Review 7.  Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids.

Authors:  Niccolò Candelise; Simone Baiardi; Alessia Franceschini; Marcello Rossi; Piero Parchi
Journal:  Acta Neuropathol Commun       Date:  2020-07-25       Impact factor: 7.801

8.  Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.

Authors:  Ivan Martinez-Valbuena; Rafael Valenti-Azcarate; Irene Amat-Villegas; Irene Marcilla; Gloria Marti-Andres; Maria-Cristina Caballero; Mario Riverol; María-Teresa Tuñon; Paul E Fraser; María-Rosario Luquin
Journal:  Acta Neuropathol Commun       Date:  2021-04-08       Impact factor: 7.801

Review 9.  Proteolytic α-Synuclein Cleavage in Health and Disease.

Authors:  Alexandra Bluhm; Sarah Schrempel; Stephan von Hörsten; Anja Schulze; Steffen Roßner
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

Review 10.  Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease.

Authors:  Dominika Fricova; Jana Harsanyiova; Alzbeta Kralova Trancikova
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.